BTCBTC
๐Ÿ’ฒ77268.60
+
6.47%
ETHETH
๐Ÿ’ฒ2422.90
+
4.17%
BNBBNB
๐Ÿ’ฒ681.33
+
4.89%
SOLSOL
๐Ÿ’ฒ91.68
+
5.42%
XRPXRP
๐Ÿ’ฒ1.39
+
9.45%
HYPEHYPE
๐Ÿ’ฒ74.96
+
4.27%

้‡‘ๅๆ•ฐๆฎ
้‡‘ๅๆ•ฐๆฎ|Aug 21, 2026 15:49
The U.S. Federal Trade Commission (FTC): Amgen's patent application acquisition deal is under antitrust review.
Share To

HotFlash

APP

X

Telegram

Facebook

Reddit

CopyLink

Hot Reads